NAD+ 1000mg

Opti-Gen NAD+ 1000 mg research vial for laboratory use only. Nicotinamide adenine dinucleotide (oxidised). Not MHRA licensed as this listing. Not for human or veterinary use.

£42.00

VAT-Included

Delivered within- 1-3 Days

7 in stock

Description

NAD +  1000mg

NAD-+ 1000 mg — Opti-Gen Peptides
For laboratory research use only.
Not for human use. Not for veterinary use.
This listing is not an MHRA-licensed medicine.

Research-grade β-nicotinamide adenine dinucleotide (oxidised form) supplied as a 1000 mg sealed vial for lawful laboratory research in the UK. Not a food, supplement, cosmetic or medical device on this page. Not for diagnostic or therapeutic use. Must not be administered to people or animals.

This is not an IV infusion product and not a licensed NAD medicine.

Identification

Product nameNAD +
Chemical nameβ-Nicotinamide adenine dinucleotide, oxidised
SupplierOpti-Gen Peptides
Contents1000 mg per vial
CAS53-84-9
FormulaC₂₁H₂₇N₇O₁₄P₂
Approx. mass~663 Da
ClassResearch cofactor / dinucleotide
Intended useLaboratory / in-vitro research only

Related lab reagents (NADH, NMN, NR) are not this vial.

Quality / storage

Only the lot COA applies. Protect from light and moisture per laboratory SOP. No infusion or injection instructions on this page.

Published research context (not product claims)

NAD + is a universal redox cofactor (NAD +/NADH) in dehydrogenase assays and a substrate for sirtuins, PARPs and related enzymes. That biochemistry is extensively published. Wellness and clinic marketing of NAD infusions is separate and is not a claim for this research material. There is no authorisation on this page for human NAD therapy.

UK notice

18+. Buyer confirms lawful laboratory research use only and will not use or resell for unauthorised human or animal use.

Additional information

Weight0.006 kg
Dimensions3 × 3 × 6 cm

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Please verify your age

You must be of legal age to enter this site.

WARNING: This website contains age-restricted content.

0